US 2022/0143049 A1Published application

A dbait molecule in combination with kinase inhibitor for the treatment of cancer

AssigneesOnxeo, Inserm (Institut National De La Sante Et De La Recherche Medicale), Universite Paul Sabatier Toulouse III, Institut Claudius Regaud

InventorsFRANÇOISE BONO, GILLES FAVRE, OLIVIER CALVAYRAC

Life of this patent

Estimating the term…

The present invention relates to the combination of a Dbait molecule with a protein kinase inhibitor for treating cancer.

Dependent claims

1-16. (canceled)

Dependencies are inferred from the claim text.

A61K 31/517
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
A61K 31/6615
Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos: compounds having two or more…
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61K 47/544
Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine: phospholipids

No related US applications are recorded in the indexed filing history.

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

Loading patent…